• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.根据亚型分析黑素瘤中 KIT 基因突变的分布和临床作用:西班牙 492 例患者研究。
Eur J Dermatol. 2021 Dec 1;31(6):830-838. doi: 10.1684/ejd.2021.3971.
2
The clinical significance of KIT mutations in melanoma: a meta-analysis.KIT突变在黑色素瘤中的临床意义:一项荟萃分析。
Melanoma Res. 2018 Aug;28(4):259-270. doi: 10.1097/CMR.0000000000000454.
3
Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.KIT 基因突变在源于与慢性和间歇性阳光暴露相关解剖部位的黑色素瘤中发生的频率较低。
Pigment Cell Melanoma Res. 2010 Apr;23(2):210-5. doi: 10.1111/j.1755-148X.2010.00671.x. Epub 2010 Jan 20.
4
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.伊马替尼治疗黏膜、肢端和慢性日光损伤皮肤来源的突变或扩增 KIT 驱动的黑色素瘤。
J Clin Oncol. 2013 Sep 10;31(26):3182-90. doi: 10.1200/JCO.2012.47.7836. Epub 2013 Jun 17.
5
GAB2 amplifications refine molecular classification of melanoma.GAB2基因扩增优化了黑色素瘤的分子分类。
Clin Cancer Res. 2009 Jul 1;15(13):4288-91. doi: 10.1158/1078-0432.CCR-09-0280. Epub 2009 Jun 9.
6
KIT amplification and gene mutations in acral/mucosal melanoma in Korea.韩国肢端/黏膜黑色素瘤中的 KIT 扩增和基因突变。
APMIS. 2011 Jun;119(6):330-5. doi: 10.1111/j.1600-0463.2011.02737.x. Epub 2011 Mar 24.
7
Large-scale analysis of KIT aberrations in Chinese patients with melanoma.大规模分析中国黑色素瘤患者中的 KIT 异常。
Clin Cancer Res. 2011 Apr 1;17(7):1684-91. doi: 10.1158/1078-0432.CCR-10-2346. Epub 2011 Feb 15.
8
KIT gene mutations and copy number in melanoma subtypes.黑色素瘤亚型中的KIT基因突变与拷贝数
Clin Cancer Res. 2008 Nov 1;14(21):6821-8. doi: 10.1158/1078-0432.CCR-08-0575.
9
Low incidence of KIT gene mutations and no PDGFRA gene mutations in primary cutaneous melanoma: an immunohistochemical and molecular genetic study of Japanese cases.原发性皮肤黑素瘤中 KIT 基因突变发生率低且无 PDGFRA 基因突变:日本病例的免疫组织化学和分子遗传学研究。
Int J Clin Oncol. 2010 Oct;15(5):453-6. doi: 10.1007/s10147-010-0087-0. Epub 2010 Apr 28.
10
Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.黑色素瘤中 KIT 表达与 KIT 突变的相关性:对 173 例病例的研究,重点关注肢端雀斑样/黏膜型。
Mod Pathol. 2009 Nov;22(11):1446-56. doi: 10.1038/modpathol.2009.116. Epub 2009 Aug 28.

引用本文的文献

1
Recent Advances in Molecular Research and Treatment for Melanoma in Asian Populations.亚洲人群黑色素瘤分子研究与治疗的最新进展
Int J Mol Sci. 2025 Jun 3;26(11):5370. doi: 10.3390/ijms26115370.
2
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma.肢端雀斑样痣黑色素瘤的综合分析显示,与皮肤黑色素瘤相比,其免疫激活下调。
Pigment Cell Melanoma Res. 2025 May;38(3):e70027. doi: 10.1111/pcmr.70027.

本文引用的文献

1
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and Metastases.原发性黑色素瘤和转移灶中 BRAF 和 NRAS 分子改变的患者内异质性。
Acta Derm Venereol. 2020 Jan 23;100(1):adv00040. doi: 10.2340/00015555-3382.
2
CD117 immunoexpression in oral and sinonasal mucosal melanoma does not correlate with somatic driver mutations in the MAPK pathway.CD117 免疫组化在口腔和鼻腔鼻窦黏膜黑色素瘤中的表达与 MAPK 通路中的体细胞驱动突变无关。
J Oral Pathol Med. 2019 May;48(5):382-388. doi: 10.1111/jop.12849. Epub 2019 Apr 5.
3
Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas.在一项对27例澳大利亚黏膜黑色素瘤的研究中,在外阴阴道黏膜黑色素瘤中发现了密码子625处SF3B1基因的复发性热点突变。
Oncotarget. 2019 Jan 29;10(9):930-941. doi: 10.18632/oncotarget.26584.
4
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations.黏膜黑色素瘤全基因组图谱分析揭示了具有临床相关性的基因组异常。
Clin Cancer Res. 2019 Jun 15;25(12):3548-3560. doi: 10.1158/1078-0432.CCR-18-3442. Epub 2019 Feb 19.
5
Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.食管原发性恶性黑色素瘤:20 例临床病理特征分析,包括 15 例肿瘤的分子遗传学特征分析。
Mod Pathol. 2019 Jul;32(7):957-966. doi: 10.1038/s41379-018-0163-y. Epub 2019 Feb 13.
6
Targeted Genomic Profiling of Acral Melanoma.肢端黑色素瘤的靶向基因组分析。
J Natl Cancer Inst. 2019 Oct 1;111(10):1068-1077. doi: 10.1093/jnci/djz005.
7
Melanoma types by in vivo reflectance confocal microscopy correlated with protein and molecular genetic alterations: A pilot study.基于体内反射共聚焦显微镜的黑色素瘤类型与蛋白和分子遗传学改变的相关性:一项初步研究。
Exp Dermatol. 2019 Mar;28(3):254-260. doi: 10.1111/exd.13877. Epub 2019 Feb 11.
8
Prevalence of BRAF, NRAS and c-KIT mutations in Slovenian patients with advanced melanoma.斯洛文尼亚晚期黑色素瘤患者中 BRAF、NRAS 和 c-KIT 突变的流行情况。
Radiol Oncol. 2018 Apr 26;52(3):289-295. doi: 10.2478/raon-2018-0017.
9
MEK inhibitors for the treatment of NRAS mutant melanoma.用于治疗NRAS突变型黑色素瘤的MEK抑制剂。
Drug Des Devel Ther. 2018 Aug 20;12:2553-2565. doi: 10.2147/DDDT.S131721. eCollection 2018.
10
Analysis of KIT gene mutations in patients with melanoma of the head and neck mucosa: a retrospective clinical report.头颈部黏膜黑色素瘤患者KIT基因突变分析:一项回顾性临床报告
Oncotarget. 2018 May 1;9(33):22886-22894. doi: 10.18632/oncotarget.25094.

根据亚型分析黑素瘤中 KIT 基因突变的分布和临床作用:西班牙 492 例患者研究。

Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.

机构信息

Laboratory of Molecular Biology, Fundación Instituto Valenciano de Oncología, València, Spain.

Department of Dermatology, Fundación Instituto Valenciano de Oncología, València, Spain.

出版信息

Eur J Dermatol. 2021 Dec 1;31(6):830-838. doi: 10.1684/ejd.2021.3971.

DOI:10.1684/ejd.2021.3971
PMID:33648909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7615026/
Abstract

BACKGROUND

KIT mutations are primarily associated with acral and mucosal melanoma, and have been reported to show higher prevalence in chronic sun-damaged (CSD) than non-CSD melanomas.

OBJECTIVES

To investigate the prevalence of KIT mutations in melanoma according to subtype, and determine the clinical role of such mutations.

MATERIALS & METHODS: We present results from a study of a Spanish population of 492 melanomas, classified according to the latest World Health Organization (WHO) guidelines. We analysed the mutational status of KIT and correlated with different clinical variables related to sun exposure and family history.

RESULTS

KIT mutations were significantly more frequent in acral (3/36; 8.3%) and mucosal (4/8; 50%) melanomas than non-acral cutaneous melanomas. No significant difference was observed in KIT mutational status between CSD and non-CSD melanomas.

CONCLUSION

Our results suggest that KIT mutations in melanoma tumours are unrelated to the development of nevi or chronic sun damage, but their presence is associated with aggressive melanomas which show ulceration, vascular invasiveness, and increased Breslow thickness. These findings are consistent with those reported by The Cancer Genome Atlas network.

摘要

背景

KIT 突变主要与肢端和黏膜黑色素瘤相关,并且已报道在慢性日光损伤(CSD)比非 CSD 黑色素瘤中更为常见。

目的

根据亚型研究黑色素瘤中 KIT 突变的发生率,并确定此类突变的临床作用。

材料和方法

我们呈现了一项针对西班牙 492 例黑色素瘤患者的研究结果,这些患者根据最新的世界卫生组织(WHO)指南进行了分类。我们分析了 KIT 的突变状态,并与与日光暴露和家族史相关的不同临床变量相关联。

结果

KIT 突变在肢端(3/36;8.3%)和黏膜(4/8;50%)黑色素瘤中比非肢端皮肤黑色素瘤更为常见。CSD 和非 CSD 黑色素瘤之间 KIT 突变状态无显著差异。

结论

我们的结果表明,黑色素瘤肿瘤中的 KIT 突变与痣或慢性日光损伤的发展无关,但它们的存在与具有溃疡、血管侵袭性和增加 Breslow 厚度的侵袭性黑色素瘤有关。这些发现与癌症基因组图谱网络报告的结果一致。